164 related articles for article (PubMed ID: 29984342)
1. Down-regulation of transient receptor potential melastatin member 7 prevents migration and invasion of renal cell carcinoma cells via inactivation of the Src and Akt pathway.
Ha YS; Kim YY; Yu NH; Chun SY; Choi SH; Lee JN; Kim BS; Yoo ES; Kwon TG
Investig Clin Urol; 2018 Jul; 59(4):263-274. PubMed ID: 29984342
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of TRPM7 prevents tumor growth, migration, and invasion through the Src, Akt, and JNK pathway in bladder cancer.
Lee EH; Chun SY; Kim B; Yoon BH; Lee JN; Kim BS; Yoo ES; Lee S; Song PH; Kwon TG; Ha YS
BMC Urol; 2020 Sep; 20(1):145. PubMed ID: 32907556
[TBL] [Abstract][Full Text] [Related]
3. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.
Liu L; Wu N; Wang Y; Zhang X; Xia B; Tang J; Cai J; Zhao Z; Liao Q; Wang J
J Exp Clin Cancer Res; 2019 Feb; 38(1):106. PubMed ID: 30819230
[TBL] [Abstract][Full Text] [Related]
4. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
5. TRPM7 Regulates AKT/FOXO1-Dependent Tumor Growth and Is an Independent Prognostic Indicator in Renal Cell Carcinoma.
Zhao Z; Zhang M; Duan X; Chen Y; Li E; Luo L; Wu W; Peng Z; Qiu H; Zeng G
Mol Cancer Res; 2018 Jun; 16(6):1013-1023. PubMed ID: 29545479
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion.
Chen WL; Barszczyk A; Turlova E; Deurloo M; Liu B; Yang BB; Rutka JT; Feng ZP; Sun HS
Oncotarget; 2015 Jun; 6(18):16321-40. PubMed ID: 25965832
[TBL] [Abstract][Full Text] [Related]
7. Transmembrane-Bound IL-15-Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin Pathway.
Yuan H; Meng X; Guo W; Cai P; Li W; Li Q; Wang W; Sun Y; Xu Q; Gu Y
Neoplasia; 2015 May; 17(5):410-20. PubMed ID: 26025664
[TBL] [Abstract][Full Text] [Related]
8. TRPM7 mediates breast cancer cell migration and invasion through the MAPK pathway.
Meng X; Cai C; Wu J; Cai S; Ye C; Chen H; Yang Z; Zeng H; Shen Q; Zou F
Cancer Lett; 2013 Jun; 333(1):96-102. PubMed ID: 23353055
[TBL] [Abstract][Full Text] [Related]
9. Transient Receptor Potential Melastatin 7 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma.
Nakashima S; Shiozaki A; Ichikawa D; Hikami S; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Otsuji E
Anticancer Res; 2017 Mar; 37(3):1161-1167. PubMed ID: 28314277
[TBL] [Abstract][Full Text] [Related]
10. Silencing TRPM7 in mouse cortical astrocytes impairs cell proliferation and migration via ERK and JNK signaling pathways.
Zeng Z; Leng T; Feng X; Sun H; Inoue K; Zhu L; Xiong ZG
PLoS One; 2015; 10(3):e0119912. PubMed ID: 25799367
[TBL] [Abstract][Full Text] [Related]
11. The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma.
Weissinger D; Tagscherer KE; Macher-Göppinger S; Haferkamp A; Wagener N; Roth W
Mol Cancer; 2013 Oct; 12(1):120. PubMed ID: 24107265
[TBL] [Abstract][Full Text] [Related]
12. TRPM7 deficiency suppresses cell proliferation, migration, and invasion in human colorectal cancer via regulation of epithelial-mesenchymal transition.
Su F; Wang BF; Zhang T; Hou XM; Feng MH
Cancer Biomark; 2019; 26(4):451-460. PubMed ID: 31640089
[TBL] [Abstract][Full Text] [Related]
13. Suppression of TRPM7 Inhibited Hypoxia-Induced Migration and Invasion of Androgen-Independent Prostate Cancer Cells by Enhancing RACK1-Mediated Degradation of HIF-1
Yang F; Cai J; Zhan H; Situ J; Li W; Mao Y; Luo Y
Oxid Med Cell Longev; 2020; 2020():6724810. PubMed ID: 32215176
[TBL] [Abstract][Full Text] [Related]
14. TRPM7 is required for ovarian cancer cell growth, migration and invasion.
Wang J; Liao QJ; Zhang Y; Zhou H; Luo CH; Tang J; Wang Y; Tang Y; Zhao M; Zhao XH; Zhang QY; Xiao L
Biochem Biophys Res Commun; 2014 Nov; 454(4):547-53. PubMed ID: 25450691
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the novel Mg2+ transporter transient receptor potential melastatin 7 (TRPM7) cation channel by bradykinin in vascular smooth muscle cells.
Callera GE; He Y; Yogi A; Montezano AC; Paravicini T; Yao G; Touyz RM
J Hypertens; 2009 Jan; 27(1):155-66. PubMed ID: 19145781
[TBL] [Abstract][Full Text] [Related]
16. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
17. TRIM13 inhibits cell migration and invasion in clear-cell renal cell carcinoma.
Li H; Qu L; Zhou R; Wu Y; Zhou S; Zhang Y; Cheng B; Ni J; Huang H; Hou J
Nutr Cancer; 2020; 72(7):1115-1124. PubMed ID: 31762344
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin promotes migration and invasion of hepatocellular carcinoma cells through TRPM7 and MMP2.
Chen Y; Yu Y; Sun S; Wang Z; Liu P; Liu S; Jiang J
Exp Cell Res; 2016 Nov; 349(1):68-76. PubMed ID: 27693494
[TBL] [Abstract][Full Text] [Related]
19. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
Li Z; Ma Z; Xu X
Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
[TBL] [Abstract][Full Text] [Related]
20. Suppression of TRPM7 inhibits proliferation, migration, and invasion of malignant human glioma cells.
Leng TD; Li MH; Shen JF; Liu ML; Li XB; Sun HW; Branigan D; Zeng Z; Si HF; Li J; Chen J; Xiong ZG
CNS Neurosci Ther; 2015 Mar; 21(3):252-61. PubMed ID: 25438992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
